ETF Managers Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-530	Closed	-$32K	–	756
2021 Q4	$32K	Sell	530 -90	-15%	-$5.43K	﹤0.01%	676
2021 Q3	$56K	Buy	620 +116	+23%	+$10.5K	﹤0.01%	653
2021 Q2	$81K	Sell	504 -21	-4%	-$3.38K	﹤0.01%	628
2021 Q1	$90K	Buy	+525	New	+$90K	﹤0.01%	642